31 May 2018
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, announces that a total of 13,289 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE Shares") were issued on 1 May 2018 (3,805 Ordinary Shares) and on 23 May 2018 (9,484 Ordinary Shares) respectively as a result of the exercise of employee share options, in connection with the Company's December 2014 - December 2017 (January 2018 Maturity) Save As You Earn Scheme.
The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of the SAYE Shares has been satisfied via the Company's block listing which was announced on 19 December 2017.
The Company also announces that 151 ordinary shares of 0.2 pence each (the "New Shares") were issued on 23 May 2018 as a result of the exercise of employee share options by a former employee, in connection with the Company's December 2015 - December 2018 (January 2019 Maturity) Save As You Earn Schemes.
Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 6 June 2018.
Following issue of the SAYE Shares and the New Shares, the Company's total issued share capital is 70,334,204 ordinary shares of 0.2 pence each with one voting right per share. The Company does not hold any ordinary shares in Treasury. This figure of 70,334,204 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Contacts: CVS Group plc Simon Innes, Chief Executive Nick Perrin, Finance Director
|
Tel: 01379 644 288 |
|
N+1 Singer (Nominated Adviser & Broker) Aubrey Powell Liz Yong
|
Tel: 020 7496 3000 |
|
|
|
|